Vitamin D Signaling

Overview

Vitamin D is a secosteroid — a steroid with an opened B ring — that functions more like a hormone than a traditional vitamin. Its active form, 1,25-dihydroxyvitamin D3 (calcitriol), binds the nuclear vitamin D receptor (VDR) and regulates the transcription of hundreds of genes across many tissues. Although vitamin D is best known for its role in bone and calcium biology, the VDR is expressed far beyond bone and intestine — in immune cells, keratinocytes, β-cells, breast, prostate, and colon — giving the pathway unexpectedly broad reach.

For peptide researchers, vitamin D signaling intersects with several peptide-relevant pathways: it regulates antimicrobial peptide expression (cathelicidin/LL-37), modulates parathyroid hormone (PTH) and FGF23 signaling, and shapes immune responses where peptide adjuvants and therapeutics act.

How It Works

Synthesis and Activation

Vitamin D3 (cholecalciferol) is synthesized in skin from 7-dehydrocholesterol under UVB light or obtained from diet. It undergoes two hydroxylations:

• 25-hydroxylation in the liver (primarily by CYP2R1) yields 25-hydroxyvitamin D3 — the major circulating form and the standard clinical measure of vitamin D status.
• 1α-hydroxylation in the kidney (and locally in many tissues) by CYP27B1 produces the active hormone 1,25(OH)2D3 (calcitriol).

CYP24A1 (24-hydroxylase) is the primary inactivating enzyme and is itself induced by calcitriol as negative feedback.

Circulating vitamin D metabolites are bound to vitamin D-binding protein (DBP).

VDR-Mediated Transcription

VDR is a member of the nuclear receptor superfamily. Calcitriol binding promotes heterodimerization with RXR, which then binds vitamin D response elements (VDREs) in target gene promoters. In the absence of ligand, VDR can either be cytoplasmic or weakly DNA-associated with corepressors; ligand binding exchanges corepressors (NCoR/SMRT) for coactivators (SRC family, Mediator complex, p300/CBP), producing a classical nuclear receptor transcriptional switch — conceptually similar to the thyroid hormone pathway and broader epigenetic regulation.

Non-Genomic Effects

Calcitriol also binds membrane-associated VDR and potentially PDIA3/1,25D3-MARRS, triggering rapid calcium influx (calcium-calmodulin pathway), PKC activation, and MAPK/ERK signaling — non-genomic effects that are fast and add another layer to vitamin D biology.

Biological Roles

Calcium and Phosphate Homeostasis

The classic "endocrine" role of calcitriol is to:

• Increase intestinal absorption of calcium (via TRPV6 and calbindin) and phosphate.
• Promote renal calcium reabsorption.
• Mobilize calcium from bone when needed.

This endocrine arm works with parathyroid hormone (PTH) and FGF23 to maintain extracellular calcium within a narrow window and enable proper bone mineralization.

Bone

Vitamin D is required for effective mineralization of osteoid. Severe deficiency causes rickets in children and osteomalacia in adults. VDR also regulates osteoclast differentiation indirectly via RANKL expression on osteoblasts.

Immune Modulation

Calcitriol suppresses Th1 and Th17 responses, promotes regulatory T cells, modulates dendritic cell maturation, and, importantly, induces the antimicrobial peptides cathelicidin (LL-37) and β-defensin 2 — a direct link between vitamin D and innate immunity that has attracted broad interest (see antimicrobial research). It also modulates NF-κB activity and interfaces with Toll-like receptor signaling.

Cellular Differentiation

VDR activation promotes differentiation and restrains proliferation in many cell types, one reason why epidemiologic associations between vitamin D status and various cancers have been explored — though causality remains debated.

Relevance to Peptides

• Cathelicidin and defensins: vitamin D is the best-characterized endogenous inducer of these antimicrobial peptides, making the pathway important in infectious disease and wound healing.
• Parathyroid hormone (PTH) and teriparatide: vitamin D and PTH are counter-regulated in calcium homeostasis; therapeutic PTH 1-34 (teriparatide) must be dosed with vitamin D sufficiency in mind.
• FGF23 peptide signaling is directly regulated by calcitriol and feeds back to suppress CYP27B1.
• Calcitonin, an opposing peptide hormone, fine-tunes calcium balance with vitamin D.

Therapeutic Implications

Cholecalciferol, ergocalciferol, calcitriol, and synthetic VDR agonists (paricalcitol, doxercalciferol) are used for deficiency, chronic kidney disease, secondary hyperparathyroidism, and psoriasis (calcipotriol topically). VDR agonists with selective transcriptional profiles aim to retain immune and antiproliferative effects while minimizing hypercalcemia. Peptide-based modulators that disrupt VDR-coactivator interfaces are used as research tools.

Current Questions

Whether vitamin D supplementation provides benefits beyond bone health in otherwise replete individuals — for cardiovascular disease, cancer prevention, autoimmune conditions, and respiratory infections — remains contested despite large trials. The field is also refining tissue-specific vitamin D actions, particularly in immunity and mitochondrial function, and evaluating peptide-based tools to dissect VDR biology with finer spatial and temporal resolution.